期刊文献+

Downregulation of MTDH using short hairpin RNA inhibited EMT in breast cancer cells

shRNA下调MTDH基因表达抑制乳腺癌细胞上皮-间质转化(英文)
下载PDF
导出
摘要 Objective: Metadherin (MTDH) could regulate epithelial-mesenchymal transition (EMT), and is involved in tumor metastasis.This study was designed to observe the effect of MTDH-short hairpin RNA (shRNA) on EMT, and the role of MTDH in breast tumor metastasis. Methods: RNA interference plasmid that can express shRNA targeting MTDH or shRNA-nega- tive plasmid that does not match any known human coding mRNA was designed, constructed and named MTDH-shRNA and MTDH-shRNA-neg, which were transiently transfected into MDA-MB-231 cells using LipofectamineTM2000. After 48 h, the levels of MTDH, E-cadherin and a-SMA expression were determined by reverse transcription-polymerase chain reactin (RT- PCR), Western blot. The invasion and immigration potential was examined by Transwell chamber invasion or migration assay. Results: Compared with MDA-MB-231, the MTDH mRNA level was down-regulated by 41.2%, the MTDH protein level was down-regulated by 40.3%. The invasion and immigration potential of MDA-MB-231 cells was decreased after transfection of MTDH-shRNA. Compared with MDA-MB-231 or MTDH-shRNA-neg, the mRNA and protein level of a-SMA was reduced and E-candherin were increased in MTDH-shRNA, with statisticat significance. Conclusion: Downregulation of MTDH increase E-candherin expression and reduced a-SMA expression, which inhibit EMT in MDA-MB-231 cells. This knockdown significantly suppresse migration and invasion in MDA-MB-231 cells.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2013年第7期326-331,共6页 中德临床肿瘤学杂志(英文版)
基金 Supported by grants from the Sub-topics of Major Discovery Platform in the 12th Five-Year Program of China (No. 2012ZX09303016-002) the Liaoning Province Science & Technology Department Funds (No. 201002060)
关键词 metadherin (MTDH) breast cancer epithelia-mesenchymal transition (EMT) invasion IMMIGRATION 乳腺癌细胞 短发夹RNA EMT mRNA水平 Western印迹 shRNA RT-PCR 肿瘤转移
  • 相关文献

参考文献16

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Can- cer J clin, 2011, 61:69-90.
  • 2Cardoso F, Harbeck N, Fallowfield L, et al. Locally recurrent or meta- static breast cancer, ESMO clinicalpractice guidelines for diagnosis,treatment and follow up. Ann Oncol, 2012, 23: 111-119.
  • 3Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its impli- cations for fibrosis. J Clin Invest, 2003, 112:1776 -1784.
  • 4Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transi- tion. J Clin Invest, 2009, 119: 1420-1428.
  • 5Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest, 2009, 119: 1429-1437.
  • 6Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in de- velopment and metastasis. Cell, 2004, 118: 277-279.
  • 7Su ZZ, Kang DC, Chen Y, et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glyeoprotein by rapid subtrac- tion hybridization, RASH. Oncogene, 2002, 21: 3592-3602.
  • 8Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer, 2002, 2: 442-454.
  • 9Yoo BK, Emdad L, Lee SG, et al. Astrocyte elevated gene-1 (AEG~I): A multifunctional regulator of normal and abnormal physiology. Phar- macol Ther, 2011, 130: 1-8.
  • 10Brown DM, Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell, 2004, 5: 365- 374.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部